Dr. Aldo Jose Peixoto, MD

Dr. Peixoto practices at Yale Medicine in New Haven, Connecticut.

Dr. Peixoto's NPI, 1073614921, was assigned on September 25, 2006. Dr. Peixoto holds Connecticut license 034142.

Dr. Peixoto's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Peixoto's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Peixoto is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Peixoto to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peixoto practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Peixoto's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Peixoto is board certified in internal medicine by the American Board of Internal Medicine. Dr. Peixoto is licensed in Connecticut.

CMS data shows 453 Medicare services from Dr. Peixoto across 6 procedure codes in 2024, for 146 Medicare patients. Medicare paid $27,748 for them.

CMS counts 146 Medicare patients who saw Dr. Peixoto in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Peixoto's median patient age at 75, with 56% women.

In 2024, Dr. Peixoto wrote 451 Medicare Part D claims for 106 patients. 92% of them were for generic drugs. CMS names the drug for 251 of them, across 11 drugs with 11 or more claims each, at $31,677 in total drug cost. In 2023, CMS named 227 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Peixoto for performance year 2024, reported as part of a group. Dr. Peixoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Peixoto as offering telehealth.

Dmand AI links 51 papers to Dr. Peixoto, published from 2007 to 2024. 2013 was the busiest year, with 4. The most frequent topics are Hypertension, Blood Pressure and Renal Dialysis. Dr. Peixoto has published most often in Am J Kidney Dis. Dr. Peixoto's most frequent co-authors are Francis P. Wilson, MD, Michael Simonov and Gary Vincent Desir, MD.

Dmand AI links Dr. Peixoto to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Hypertension and Vascular Diseases.

CMS Open Payments shows 43 general payments to Dr. Peixoto from 10 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 76% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $10,773. It also lists 8 research payments totaling $1,454 from 2017 to 2024.